Chronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
May 08, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 08, 2023 (GLOBE NEWSWIRE) -- Chronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsight Chronic kidney disease (CKD) is a...
Dialysis Machines Market Projected to Reach US$24.5 Billion by 2033: Growing Prevalence of Kidney Diseases to Drive Demand | Persistence Market Research
April 13, 2023 10:40 ET
|
Persistence Market Research
New York, April 13, 2023 (GLOBE NEWSWIRE) -- The Dialysis Machines Market is predicted to grow from an estimated USD 18.1 billion in 2022 to USD 24.5 billion between 2022 and 2033, at a CAGR of...
Kidney Function Tests Global Market Report 2022: Sector to Reach $1.39 Billion by 2030 at a CAGR of 6.5%
February 27, 2023 08:38 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests, Dilution And Concentration...
Kidney Transplant Market will increase by around US$ 9.1 Billion by 2033 | Future Market Insights, Inc.
February 27, 2023 04:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 27, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, the valuation for the global Kidney Transplant Market was around US$ 5.8 Billion in 2022 and...
Global Kidney Function Tests Market Report 2028: Featuring Baxter International, Abbott Laboratories, Sysmex, F. Hoffmann-La Roche and Danaher Among Others
February 23, 2023 08:08 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Urine Tests, Blood Tests),...
Arch Scientist Awarded CIHR Grant to Study the Role of Dipeptidase-1 in Chronic Kidney Disease
February 07, 2023 07:05 ET
|
Arch Biopartners
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of...
Panoramic Health Expands Executive Management With Three Key Appointments
December 08, 2022 12:01 ET
|
Panoramic Health
TEMPE, Ariz., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Panoramic Health℠, the leading integrated value-based kidney care platform in the U.S., continues its expansion and growth delivering better outcomes...
Panoramic Health Launches Clinical Research Division to Drive Discovery of Novel Kidney Disease Therapies
October 26, 2022 08:00 ET
|
Panoramic Health
TEMPE, Ariz., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Today, Panoramic Health℠, the nation's leading integrated value-based kidney care platform, announced the launch of its clinical research division...
Chronic Kidney Disease [CKD] Nutritional Supplement Market to Exceed Value of US$ 5.0 Bn by 2031, Notes TMR Report
August 31, 2022 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global chronic kidney disease [CKD] nutritional supplement market size is...
Clarus Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease
March 16, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first and only FDA-approved oral softgel for testosterone (T) replacement therapy in adult males who have deficient T due to certain medical conditions Clarus expects to announce...